Ondine Financial Statements From 2010 to 2024

Stocks . UK . 
Stock . Ondine Biomedical
OBI Stock   8.00  0.13  1.60%   
Ondine Biomedical financial statements provide useful quarterly and yearly information to potential Ondine Biomedical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ondine Biomedical financial statements helps investors assess Ondine Biomedical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ondine Biomedical's valuation are summarized below:
Gross Profit
1.3 M
Market Capitalization
34.1 M
Enterprise Value Revenue
36.3446
Revenue
1.6 M
Earnings Share
(0.03)
There are over eighty-two available trending fundamental ratios for Ondine Biomedical, which can be analyzed over time and compared to other ratios. Investors should ensure to check out all of Ondine Biomedical's recent performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road.

Ondine Biomedical Total Revenue

943,339

Check Ondine Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ondine Biomedical's main balance sheet or income statement drivers, such as Other Operating Expenses of 11.8 M, Total Operating Expenses of 11.2 M or Income Tax Expense of 89.3 K, as well as many indicators such as . Ondine financial statements analysis is a perfect complement when working with Ondine Biomedical Valuation or Volatility modules.
  
This module can also supplement various Ondine Biomedical Technical models . Check out the analysis of Ondine Biomedical Correlation against competitors.

Ondine Biomedical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets9 M5.7 M7.7 M
Slightly volatile
Total Current Liabilities3.3 M3.5 M12.4 M
Very volatile
Property Plant And Equipment Net663.6 K949 K456.4 K
Slightly volatile
Accounts Payable923 K1.4 M588 K
Slightly volatile
Cash4.5 M3 M4.4 M
Slightly volatile
Non Current Assets Total1.3 M984 K2 M
Slightly volatile
Non Currrent Assets Other33.2 K35 K101.5 K
Slightly volatile
Cash And Short Term Investments5.6 M3 M4.5 M
Slightly volatile
Net Receivables269.6 K220 K117.4 K
Slightly volatile
Common Stock Shares Outstanding101.2 M197.1 M168 M
Very volatile
Liabilities And Stockholders Equity9 M5.7 M7.7 M
Slightly volatile
Non Current Liabilities Total151.1 K159 K1.6 M
Very volatile
Other Stockholder Equity33 M28.8 M16.4 M
Slightly volatile
Total Liabilities3.5 M3.6 M12.6 M
Very volatile
Total Current Assets7.7 M4.8 M5.7 M
Slightly volatile
Short and Long Term Debt Total514 K541 K10.6 M
Very volatile
Other Current Assets1.1 M703 K580.5 K
Slightly volatile
Short Term Debt362.9 K382 K10.5 M
Very volatile
Inventory646.2 K1.1 M671.4 K
Slightly volatile
Intangible Assets186.8 K196.7 K1.5 M
Slightly volatile
Short Term Investments6.6 M5 M6 M
Slightly volatile
Capital Surpluse4.6 M7.3 M6 M
Slightly volatile
Common Stock132.6 M239.6 M138.9 M
Slightly volatile
Property Plant Equipment532.7 K540.9 K653.1 K
Slightly volatile
Other Liabilities93.1 K133.1 K143.1 K
Slightly volatile
Current Deferred Revenue1.4 M1.4 M949.3 K
Slightly volatile
Capital Lease Obligations469.7 K541 K204.2 K
Slightly volatile
Net Invested Capital2 M2.1 M4.9 M
Pretty Stable
Capital Stock195.9 M239.6 M148 M
Slightly volatile
Property Plant And Equipment Gross2.3 M2.4 M2.8 M
Slightly volatile
Other Assets32.4 K31.5 K42.7 K
Slightly volatile
Non Current Liabilities Other51.3 K54 K477 K
Slightly volatile

Ondine Biomedical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses11.8 M16 M10.6 M
Slightly volatile
Total Operating Expenses11.2 M15.5 M10.2 M
Slightly volatile
Depreciation And Amortization517.3 K587 K643.2 K
Pretty Stable
Interest Expense36.1 K38 K615.1 K
Slightly volatile
Selling General Administrative7.8 M8 M6 M
Slightly volatile
Total Revenue943.3 K1.2 M832.3 K
Slightly volatile
Cost Of Revenue499.4 K500 K520.8 K
Pretty Stable
Selling And Marketing Expenses1.3 M1.8 M899.9 K
Slightly volatile
Research Development4.5 M5.1 M3.8 M
Slightly volatile
Reconciled Depreciation660.7 K587 K866.1 K
Slightly volatile
Minority Interest2.7 K1.8 K2.8 K
Slightly volatile

Ondine Biomedical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow13.9 M13.3 M4.7 M
Slightly volatile
End Period Cash Flow4.5 M3.1 M4.4 M
Slightly volatile
Depreciation571 K587 K457.5 K
Slightly volatile
Other Cashflows From Investing Activities568.4 K598.3 K718.5 K
Slightly volatile
Net Borrowings7.4 M7.1 M4.4 M
Slightly volatile
Change To Netincome1.2 M1.3 M8.8 M
Very volatile
Change To Liabilities438.2 K284.1 K390.1 K
Slightly volatile

Ondine Fundamental Market Drivers

Cash And Short Term Investments3 M

About Ondine Biomedical Financial Statements

Ondine Biomedical stakeholders use historical fundamental indicators, such as Ondine Biomedical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ondine Biomedical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ondine Biomedical's assets and liabilities are reflected in the revenues and expenses on Ondine Biomedical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ondine Biomedical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.4 M1.4 M
Total Revenue1.2 M943.3 K
Cost Of Revenue500 K499.4 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ESRTEmpire State Realty
CCitigroup
CCitigroup

Other Information on Investing in Ondine Stock

Ondine Biomedical financial ratios help investors to determine whether Ondine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ondine with respect to the benefits of owning Ondine Biomedical security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY